Skip to content

Evaluation of Digital Stabilizing Splint in Management of Masticatory Muscle Disorder

Evaluation of Digital Stabilizing Splint in Management of Masticatory Muscle Disorder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06138535
Enrollment
8
Registered
2023-11-18
Start date
2022-09-30
Completion date
2023-11-10
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Muscle Disorder

Brief summary

The goal of this clinical trial is to evaluate the digital stabilizing splint in management of masticatory muscle disorder. The main question it aims to answer are: • is the digital stabilizing splint effective in treatment of masticatory muscle disorder signs and symptoms after 3 months follow up ? Participants will be asked to ware the splint and progressively increasing the duration of splint wear, starting from 8 hours per day for 3 months .

Detailed description

The current research was conducted for evaluation of the digital stabilizing splint in the management of masticatory muscle disorder. Subjects and Methods: Eight patients over the age of 18 with masticatory muscle disorders received treatment using a stabilizing splint that was digitally created. The Each patient's response to therapy modifications was assessed and compared before and after splint insertion for each patient subjective symptoms were assessed using a patient questionnaire that was repeated before treatment (baseline), one month, and 3 months post-insertion. Moreover, The masseter and temporalis muscles' electrical activity was measured using electromyography at baseline and after three months.post-splint insertion. Clinical signs such as mouth-opening lateral movements and protrusive movements were measured before and 3 months after the splint was inserted.

Interventions

3D Printed stabilizing splint that has been digitally designed on a modern software

Sponsors

Al-Azhar University
CollaboratorOTHER
zahraa hassan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

single arm group study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1-Anterior disc displacement without reduction or osteoarthritis cases 2-Pain and/or tenderness of masticatory muscles

Exclusion criteria

1. Absence of previous occlusal splint therapy. 2. Absence of apparent dental or periodontal diseases. 3. Patients having full or partial dentures that would compromise the support of an occlusal splint were excluded. 4. Patient taking analgesics, muscle relaxants, or Anti-inflammatory medications will not be included because they may affect the outcome. 5. Patients with multiple teeth loss that affects occlusal splint support were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Patient questionnaire (clinical symptoms).3 monthsPatient questionnaire (clinical symptoms) . The questionnaire was used to detect the clinical symptoms scoring that ranges from 0 to 10 (10 being greatest pain/dysfunction and 0 signifying no pain/proper function). The success or failure was determined by the reduction in pain and dysfunction postoperatively. the scales were taken for all eight patients before and after 3 months of treatment. the questionnaire included questions about different clinical symptoms as following: headaches, facial discomfort, jaw joint pain, pain during mastication, neck pain, difficulty opening the mouth, difficulty in jaw movements, complaints during chewing, and clenching habits.

Secondary

MeasureTime frameDescription
Clinical sign such as mouth opening3 monthsClinical sign such as mouth opening that was recorded by measuring the distance between the upper and lower central incisors by a caliper in millimeters unit. the increase in mouth opening indicates positive clinical improvement. the mouth opening was measured before and after 3 months of treatment.

Other

MeasureTime frameDescription
Evaluation of muscle activation with surface electromyography (EMG)3 monthsEvaluation of muscle activation with surface electromyography (EMG) for each of the eight patients enrolled in our study, and the records were taken before and after 3 months of treatment. The surface electrodes were placed on the anterior temporalis and the superficial masseter muscles. A Fast Fourier Transform ( FFT ) was carried out using the software of electromyography. The mean value of the EMG activity of each muscle was calculated from the amplitude in microvolts ( μV ). The decrease in the muscle records was an indication of improvement of muscle activity.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026